U.S. Medical Cannabis Market Sizeembed
The medical marijuana market is at the nascent stage of development and is expected to grow significantly during the forecast period owing to rising consumer demand.
Your CatalystTo a Lucrative Business U.S. Medical Cannabis Market Share, Size, Analysis, Growth, Regional Outlook, Trends and Forecasts to 2024 | Hexa Research "U.S. Medical Cannabis Market Size Worth USD 19.48 Billion By 2024." The U.S. Medical Cannabis Market is expected to be valued at USD 19.48 billion by 2024, driven by its numerous medical benefits particularly by patients suffering from cancer, chronic pain and diabetes. Favorable regulatory environment across numerous states including California and Colo rado is expected to fuel the growth of the market over the next few years. Medical Marijuana Regulation and Safety Act implemented in 2015 permits the cultivation and use of cannabis dispensaries at the state and local level which has been one of key drivers to fuel the U.S market. The rising number of states receiving approval to utilize cannabis for consumption in medical cases is expected to be one of the crucial factors to upsurge the demand for medical marijuana over the forecast period. Browse Details of Report @ https://www.hexaresearch.com/research-report/us-medical-cannabis-market Follow Us: Your CatalystTo a Lucrative Business Over the past few decades, there have been several controversies surrounding legalization of cannabis for medical purposes; however, increasing signs of medical benefits received from the consumption of cannabis has resulted in the herb being legalized across various states in the nation. The industry is expected to witness significant growth during the forecast period owing to greater consumer acceptance along with an increasing number of companies entering the market. The symptoms and conditions that can be treated by the herb include cancer, arthritis, epilepsy, nausea, pain Alzheimer’s disease, anorexia, AIDS, HIV, glaucoma, cachexia, Crohn’s disease, migraines, and multiple sclerosis. Chronic pain accounted for 46% of the U.S. cannabis medical market share i n 2016. The ability of medical marijuana to curb pain is expected to gain popularity among patients diagnosed with chronic illnesses and pain. In 2016, solid edibles segment dominated the U.S market generating revenues worth USD 2.47 billion and is expected to continue dominating the industry over the forecast period. The future product innovation and potential growth are substantial owing to continuous development from the consumption of cannabis infused products owing to their numerous applications including lotions, bath salts, shampoo, lip balm, toothpaste, coffee pods, baked brownies cookies, candy, confectioneries, beverages, vinegar and oils. California is known to be the first state in U.S. that legalized cannabis for medical purpose. In 2016, Cali fornia recorded the highest revenue generation and is expected to grow at a CAGR of 13% over the projected period. Over the next few years, more number of state governments are expected to legalize cannabis owing to its numerous benefits which will fuel its growth over the projected period. Hexa Research has segmented the U.S. medical cannabis market based on usage, consumption and state: Segmentation by usage, 2014 - 2024 (USD Million) • Chronic Pain • Arthritis • Migraine • Cancer • Others Segmentation by consumption, 2014 - 2024 (USD Million) • Solid Edibles • Inhalation • Liquid Edibles • Topical Segmentation by state, 2014 - 2024 (USD Million) • California • Colorado • Washington • Arizona • Michigan Follow Us: Your CatalystTo a Lucrative Business Key players analyzed • American Cannabis • Canopy Growth Corporation • Greengro Technologies • Medical Marijuana Inc. • United Cannabis • Terra Tech Corp. • Mentor Capital, Inc • Cannabis Sativa, Inc. • GBSciences, Inc. • The Green Solution Browse Related Category Market Reports @ https://www.hexaresearch.com/researchcategory/healthcare-industry Follow Us: Your CatalystTo a Lucrative Business Table of Content of U.S. Medical Cannabis Market Chapter 1. Market Summary 1.1. Market trends & movement Chapter 2. U.S. Medical Cannabis Market Trends: Drivers & Opportunities 2.1. Introduction 2.2. Key industry trends 2.3. Market drivers 2.4. Market restraints 2.5. Value chain analysis 2.6. Porter's Five Forces analysis 2.7. SWOT Chapter 3. U.S. Medical Cannabis Market Trends, By Usage 3.1. U.S. Medical Cannabis market movement, by usage, 2016 & 2024 3.1.1. Chronic Pain 22.214.171.124. Market estimates and forecast, 2014 - 2024 (USD Million) 3.1.2. Arthritis 126.96.36.199. Market estimates and forecast, 2014 - 2024 (USD Million) 3.1.3. Migraine 188.8.131.52. Market estimates and forecast, 2014 - 2024 (USD Million) 3.1.4. Cancer 184.108.40.206. Market estimates and forecast, 2014 - 2024 (USD Million) 3.1.5. Others 220.127.116.11. Market estimates and forecast, 2014 - 2024 (USD Million) Chapter 4. U.S. Medical Cannabis Market Trends, By Consumption 4.1. U.S. Medical Cannabis market movement, by consumption, 2016 & 2024 4.1.1. Solid edibles 18.104.22.168. Market estimates and forecast, 2014 - 2024 (USD Million) 4.1.2. Inhalation 22.214.171.124. Market estimates and forecast, 2014 - 2024 (USD Million) 4.1.3. Liquid edibles 126.96.36.199. Market estimates and forecast, 2014 - 2024 (USD Million) 4.1.4. Topical 188.8.131.52. Market estimates and forecast, 2014 - 2024 (USD Million) Chapter 5. U.S. Medical Cannabis Market Trends, By State 5.1. U.S. Medical Cannabis market movement, by state, 2016 & 2024 Follow Us: Your CatalystTo a Lucrative Business 5.1.1. California 184.108.40.206. Market estimates and forecast, 2014 - 2024 (USD Million) 5.1.2. Colorado 220.127.116.11. Market estimates and forecast, 2014 - 2024 (USD Million) 5.1.3. Washington 18.104.22.168. Market estimates and forecast, 2014 - 2024 (USD Million) 5.1.4. Arizona 22.214.171.124. Market estimates and forecast, 2014 - 2024 (USD Million) 5.1.5. Michigan 126.96.36.199. Market estimates and forecast, 2014 - 2024 (USD Million) Chapter 6. Competitive Landscape 6.1. Competitive landscape analysis, 2016 6.2. Strategic framework 6.3. Potential customer base concentration 6.4. Company market positioning 6.5. Company profiles 6.5.1. American Cannabis 188.8.131.52. Company Overview 184.108.40.206. Product Benchmarking 220.127.116.11. Financial Performance 18.104.22.168. Recent Initiatives 6.5.2. Canopy Growth Corporation 22.214.171.124. Company Overview 126.96.36.199. Product Benchmarking 188.8.131.52. Financial Performance 184.108.40.206. Recent Initiatives 6.5.3. Greengro Technologies 220.127.116.11. Company Overview 18.104.22.168. Product Benchmarking 22.214.171.124. Financial Performance 126.96.36.199. Recent Initiatives 6.5.4. Medical Marijuana Inc. 188.8.131.52. Company Overview 184.108.40.206. Product Benchmarking 220.127.116.11. Financial Performance 18.104.22.168. Recent Initiatives Follow Us: Your CatalystTo a Lucrative Business 6.5.5. United Cannabis 22.214.171.124. Company Overview 126.96.36.199. Product Benchmarking 188.8.131.52. Financial Performance 184.108.40.206. Recent Initiatives 6.5.6. Terra Tech Corp. 220.127.116.11. Company Overview 18.104.22.168. Product Benchmarking 22.214.171.124. Financial Performance 126.96.36.199. Recent Initiatives 6.5.7. Mentor Capital, Inc 188.8.131.52. Company Overview 184.108.40.206. Product Benchmarking 220.127.116.11. Financial Performance 18.104.22.168. Recent Initiatives 6.5.8. Cannabis Sativa, Inc. 22.214.171.124. Company Overview 126.96.36.199. Product Benchmarking 188.8.131.52. Financial Performance 184.108.40.206. Recent Initiatives 6.5.9. GBSciences, Inc 220.127.116.11. Company Overview 18.104.22.168. Product Benchmarking 22.214.171.124. Financial Performance 126.96.36.199. Recent Initiatives 6.5.10. The Green Solution. 188.8.131.52. Company Overview 184.108.40.206. Product Benchmarking 220.127.116.11. Financial Performance 18.104.22.168. Recent Initiatives 6.5.11. List of other vendors Chapter 7. Methodology and Scope 7.1. Research methodology 7.2. Research Scope & Assumptions 7.3. List of data sources Follow Us: Your CatalystTo a Lucrative Business About Us: Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives. Contact Us: Ryan Shaw Hexa Research Felton Office Plaza 6265 Highway 9 Felton, California 95018 United States Phone: +1-800-489-3075 Email: [email protected] Website - https://www.hexaresearch.com Follow Us: